“Ocular Hypotensive Efficacy of a New Liposomal Latanoprost Formulation Administered by Different Routes for Experimental Ocular Hypertension”. 2025. Ukrainian Journal of Ophthalmology , no. 2 (August): 37-41. https://doi.org/10.31288/oftalmolzh202223741.